Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page history shows a site release update: Revision: v3.3.2 added and Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:25:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Version label updated from v3.2.0 to v3.3.1 in the page footer; no visible changes to study data or primary content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:42:59.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page, and core trial history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:22:00.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The new version updates the study status and the list of contacts/locations compared with the previous version. These changes reflect shifts in recruitment status and site availability.
    Difference
    0.0%
    Check dated 2025-11-03T01:05:42.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Page now shows a newer date and updated study-status entry, replacing an older date; overall meaning shifts toward current status information without affecting core transactional elements.
    Difference
    0.6%
    Check dated 2025-10-12T14:25:29.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    9%
    Check dated 2025-10-05T10:05:55.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.